Table 2

Estimate of the number of patients eligible for ramipril treatment in the UK population. Data from the HOPE trial were used to quantify the number of lives gained annually on treatment

Eligible population New prescriptions (%) Net cost (total cost)
(£ million)
Lives gained per year
Total population⩾ 3000000100500 (500)12000
IHD31 14000007030 166 (240)5600
Stroke21 60000095100 (102)2400
Diabetes21 170000050144 (288)6800
PVD21 100000099180 (180)4000
  • IHD, ischaemic heart disease; PVD, peripheral vascular disease.